In addition, we found that β6 silencing significantly decreased Rac1-GTPase activity (Fig. 6D), while β6 overexpression increased Rac1 activity in cholangiocarcinoma cells (Fig. 6E). This evidence concerns the gene RAC1 and cholangiocarcinoma.